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As peripheral nerves generate the signals that govern both 
pain and peripheral motor function, dysfunction of periph-
eral nerves is inherently debilitating. Chronic nerve injuries 
may be considered those injuries that manifest in patients 
seeking outpatient care. These may result from an untreated 
acute injury to a nerve, or may result from a progressive 
chronic process, such as untreated compression neuropathy.
Nerve injuries often present with an obvious loss of 
function that may impart substantial disability and impair 
activities of daily living, ability to work, or to pursue rec-
reation.1–4 Untreated chronic neuropathic pain due to 
nerve injury, although impossible to define objectively by 
an examiner, may have a multitude of equally disabling 
effects on an individual’s quality of life (QoL). Chronic 
pain may induce or exacerbate psychological stress and 
depression,5 and may result in chronic emotional, behav-
ioral, and even personality changes.1 Furthermore, 
chronic pain may interfere with ability to work, sleep, 
engage in social activities, and ability to pursue leisure or 
hobbies.1 Pain has been demonstrated to be specifically 
predictive of negative changes in QoL and mood,6 and the 
reported intensity of a patient’s pain has been shown to be 
predictive of the level of disability imparted by the nerve 
injury.2,3
Time since injury is also predictive of the level of 
disability,2 and this time may be increased by delays in 
referral, treatment and attempted treatment with inef-
fective modalities, whether medical or interventional. 
John M. Felder, MD*
Ivica Ducic, MD, PhD† 
 
Background: Little emphasis has been paid to characterize quality of life (QoL) 
burdens experienced by patients seeking surgical treatment for nerve injuries and 
neuropathic pain.
Methods: A cross-sectional survey was distributed to all patients (N = 767) from a 
single nerve surgeon’s practice between 2014 and 2019. Data collected included 
demographics, specifics of the injury and symptoms, time to referral, and effects of 
the injury, surgery, and timing of surgery on QoL.
Results: Of the 767 patients, 209 (27.2%) completed the survey. Average age was 48.8 
years; 68.9% of patients were women and 31.1% men. At presentation, 68% had expe-
rienced symptoms for more than 1 year; 86.1% reported severity as being profound; 
97.6% reported QoL was at least moderately negatively impacted by nerve injury; 70% 
felt they should have been referred earlier for surgical evaluation; 51.2% were not 
told that nerve surgery was an option for their problem; 83.1% felt that earlier refer-
ral would have improved their QoL. After surgery, symptoms were significantly miti-
gated in 55.5% of the patients, moderately mitigated in 21.5%. Patients reported QoL 
was significantly (59.8%) or at least moderately (76.6%) improved by nerve surgery.
Conclusions: The majority of patients reported that nerve injuries imparted a mod-
erate to severe impact on QoL, and that surgical treatment improved QoL. Most 
patients felt that earlier referral for surgical intervention would have led to bet-
ter outcome and positively impacted QoL. Interdisciplinary treatment algorithms, 
including a role for surgical intervention, may be helpful in facilitating timely 
diagnosis, referral, and thus improved outcomes. (Plast Reconstr Surg Glob Open 
2021;9:e3570; doi: 10.1097/GOX.0000000000003570; Published online 21 May 2021.)
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Medications (opioids, neuroleptics, and antidepressants) 
used chronically for pain related to nerve injuries may 
themselves lead to further undesirable effects.7
Although neuropathic pain has been repeatedly dem-
onstrated to represent a negative burden on QoL in 
patients treated pharmacologically,7,8 there is surprisingly 
little information available in the literature examining 
QoL burdens reported by patients seeking nerve sur-
gery, or examining the effect of nerve surgery on QoL. 
We therefore sought to characterize the burden of nerve 
injuries on QoL in patients seeking surgery for these con-
ditions. The objectives of this study were (i) to character-
ize patient-reported effects of chronic nerve injuries on 
quality of life, across a broad range of conditions present-
ing for ambulatory treatment; (ii) to examine the effect 
of nerve surgery on patient-reported QoL, and (iii) to 
characterize patients’ feelings about timing of referral to a 
surgeon and delays in treatment.
METHODS
An institutional review board (IRB)-approved retro-
spective cross-sectional survey was distributed to all patients 
(N = 767) from a single nerve surgeon’s (ID) ambulatory 
referral-based practice between 2014 and 2019. Minimum 
follow up was 1 year. Data collected included demographics, 
reason of injury, concurrent clinical conditions, specifics of 
nerve injury/disorder type, symptom of the injury and the 
severity, time to referral, severity of the symptoms, how the 
QoL was affected, feelings regarding the process of finding 
treatment, post-surgery impacts on symptoms and QoL, and 
complications of surgery.
RESULTS
Characteristics of the Patient Group
Of the 767 patients, 209 (27.2%) completed the survey. 
Average age was 48.8 (SD = 19.1) years; 68.9% were women 
and 31.1% men. Notable comorbidities included anxiety 
(31.1%), depression (28.2%), and thyroid disorders (11.0%) 
(Table  1). The composition of the response group versus 
non-responders to the survey is characterized in Table 2.
Presenting symptoms included: pain 192 (91.9%), 
numbness 82 (39.2%), tingling/burning 129 (61.7%), 
muscle weakness 45 (21.5%), difficulty using arm or leg 
46 (22%), headaches /migraines 111 (53.1%), and others 
< 10% (Table 1).
Specifically, the symptoms affecting quality of life 
included: sleep pattern in 78.5% of the patients, social life 
in 87.5%, extremity function in 44.0%, personal/social 
life in 87.6%, professional activities in 71.8%, and mood/
spirits in 83.7% (Table 1).
The duration of symptom before presentation is distrib-
uted as: <3 months (3.8%), 3–6 months (8.1%), 6–12 months 
(20.1%), 1–2 years (25.8%), 3–5 years (21.1%), 5–10 years 
(10.0%), and >10 years (11.0%). An estimated 68% (95% con-
fidence interval [CI] = [61.2%, 74.2%]) of the patients had 
symptoms for more than 1 year before surgery (Figs. 1, 2).
Table 1. Patient Demographics
Age 
Avg 48.8 SD 19.1




Survey respondents 209 27.2
Gender   
 Men 65 31.1
 Women 144 68.9
Comorbidities   
 No major comorbidities 77 36.8
 Anxiety 65 31.1
 Depression 59 28.2
 Peripheral vascular disease 31 14.8
 Thyroid disorders 23 11
 Autoimmune diseases 18 8.6
 Diabetes 13 6.2
 Cancer 10 4.8
Presenting symptoms   
 Pain 192 91.9
 Numbness 82 39.2
 Tingling/burning 129 61.7
 Muscle weakness 45 21.5
 Difficulty using arm or leg 46 22
 Headaches/migraines 111 53.1
QoL variables affected   
 Sleep 164 78.5
 Ambulation/use of extremity 92 44
 Personal/social life 183 87.6
 Professional activities 150 71.8
 Mood/spirits 175 83.7










Age     
 Mean ± SD 43.71 ± 18.52 48.80 ± 19.07   
Gender     
 Women 503 (65.58%) 144 (68.90%) 359 (64.33%) P = 0.267
WC versus insurance     
 WC 110 (14.34%) 28 (13.40%) 82 (14.70%) P = 0.729
Surgery type     
 Neurolysis 455 (59.32%) 108 (51.67%) 347 (62.18%) P = 0.011
 Neuroma excision + implantation to muscle 42 (5.48%) 7 (3.33%) 35 (6.27%) P = 0.153
 Excision and reconstruction 256 (33.38%) 90 (42.86%) 166 (29.74%) P = 0.001
 Nerve tumor 14 (1.83%) 4 (1.90%) 10 (1.79%) P = 1.000
Anatomical area     
 Head & neck 484 (63.10%) 118 (56.46%) 366 (65.59%) P = 0.023
 Breast/chest 4 (0.52%) 2 (0.96%) 2 (0.36%) P = 0.300
 Upper extremity 71 (9.26%) 20 (9.57%) 51 (9.14%) P = 0.889
 Lower extremity 163 (21.25%) 62 (29.67%) 101 (18.10%) P = 0.001
 Trunk/groin 45 (5.87%) 6 (2.87%) 38 (6.99%) P = 0.037
WC, worker's compensation.
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Anatomical areas affected included: head and neck 
in 119 patients (56.9%), lower extremity in 62 (29.7%), 
upper extremity in 19 (9.1%), trunk/groin in 6 (2.9%), 
breast in 2 (1%), and multiple areas in 1 (0.5%) (Table 1). 
An estimated 16.3% had spontaneous onset, 53.1% had 
suffered a physical trauma, and 30.6% were precipitated 
by previous surgery.
Surgery types included neurolysis in 108 (51.67%) 
patients, neuroma excision with implantation to muscle 
in 7 (3.33%), neuroma excision and nerve reconstruction 
in 90 (42.86%), and excision of nerve tumor in 4 (1.90%) 
(Table 2).
Severity of Symptoms before and after Surgery
86.1% (95% CI = [80.7%, 90.5%]) of the patients 
reported the severity of symptoms at presentation being 
profound, with a mean ± SD preoperative Likert scale 
pain score of 8.1 ± 2 (median 9) (Fig. 3). After the sur-
gery, 9.1% (95% CI = [5.6%, 13.8%]) reported that the 
severity of symptoms was profound, a 77% reduction from 
pre-surgery symptoms (P < 0.001 by McNemar’s test). The 
mean ± SD Likert scale (0–10) pain severity score was 3.2 ± 
3.0 (median=2). The change (reduction mean ± SD = 4.9 
± 3.6; median = 5) was statistically significant (P < 0.001 by 
the Wilcoxon Rank Sum test) (Fig. 4).
Fig. 1. Symptom frequency and duration.
Fig. 2. anatomical areas affected.
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Patients reported that symptoms were significantly mit-
igated in 55.5% of the patients, moderately mitigated in 
21.5%, somewhat mitigated in 10.0%, and 12.9% felt that 
surgery was not helpful (Fig. 5).
Quality of Life before and after Surgery
84.7% (95% CI = [79.1%, 89.3%]) reported their QoL 
was significantly negatively impacted by their nerve injury, 
and 97.6% (95% CI = [94.5%, 99.2%]) reported their QoL 
was at least moderately negatively impacted by their nerve 
injury, which suggests with 95% statistical confidence that 
more than 79.1% of the patients’ QoL was significantly 
negatively impacted by their nerve injury (Fig. 6). 59.8% 
(95% CI = [52.8%, 66.5%]) reported their QoL was sig-
nificantly improved by their nerve surgery treatment; and 
76.6% (95% CI = [70.2%, 82.1%]) reported their QoL was 
at least moderately improved by their nerve surgery treat-
ment (Fig. 7).
The surgery positively affected: 68.3% of those whose 
sleep pattern was affected by the symptom; 75.0% of 
those whose extremity function was affected by the 
symptom; 74.9% of those whose personal/social life was 
Fig. 3. Symptom severity at time of presentation.
Fig. 4. the effect of nerve surgery on reduction of nerve symptom severity.
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affected by the symptom; 66.0% of those whose profes-
sional productivity was affected by the symptom; and 
76.6% of those whose mood/spirits was affected by the 
symptom (Fig. 7).
Treatment Experiences before Surgery and Feelings on the 
Referral Process
With regard to treatment experiences before the pre-
sentation, the distribution of total number of physicians 
seen: 0 (0%), 1–3 (28.7%), 4–6 (42.1%), 7–10 (16.7%), 
11–15 (7.7%), 16–20 (4.8%) (Fig. 8). In total, 70.0% (95% 
CI = [63.1%, 76.0%]) felt they should have been referred 
earlier; 51.2% (95% CI = [44.2%, 58.2%]) were not told 
that nerve surgery was an option for their problem; and 
68.8% (95% CI = [62.0%, 75.0%]) were told that nothing 
could be done. An estimated 83.1% (95% CI = [77.3%, 
87.9%]) felt that earlier referral would have improved 
their quality of life, and 88.5% (95% CI = [83.3%, 92.5%]) 
stated that if they could go back in time, they would have 
the surgery again (Figs. 9–11).
Fig. 5. the degree to which nerve surgery helped resolve nerve symptoms.
Fig. 6. impact of nerve injuries on quality of life at presentation.
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The average overall satisfaction with nerve surgery 
was 8.04/10—48.8% rated 10/10 (Fig. 12). Complication 
rate was 8.3%, and all complications were minor (delayed 
wound healing, dehiscence due to noncompliance, infec-
tion requiring oral antibiotics), with no complications 
requiring hospitalization or return to the operating room 
(Fig. 13).
DISCUSSION
Traditional outcomes reporting in nerve surgery 
focuses on objective clinical motor or sensory grading 
systems. However, patients themselves may experience 
the impact of nerve injuries and outcome of nerve surger-
ies very differently. The pain and bodily dysfunction that 
clinicians seek to characterize are in reality only some of 
the contributors to the overall negative impact that nerve 
injuries create on a patient’s quality of life. Pain and sen-
sory/motor dysfunction are a problem because they cre-
ate a negative change in patients’ standard of living that 
they are unable to overcome without medical interven-
tion. This negative chapter in a patient’s life story can be 
unduly extended when treating clinicians do not diag-
nose the problem correctly or do not refer the patient for 
appropriate nerve surgery intervention, which is often the 
Fig. 7. impact of nerve surgery on improving quality of life.
Fig. 8. Other physicians seen before referral to nerve surgeon.
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only means of permanently restoring or at least approxi-
mating the patient’s prior quality of life.
It has been our observation over 2 decades of clinical 
practice that patients’ interpretation of their experience 
does not always correlate with either objective outcome 
measures, or validated surrogate measures aimed at quan-
tifying QoL variables. Therefore, this study was designed 
to directly query surgical patients’ perceptions of the 
quality of life changes imparted by nerve injuries, and the 
effect of nerve surgery on quality of life. This study was 
administered as a cross-sectional survey intended to cap-
ture patient perceptions following the conclusion of their 
experience with nerve surgery. Although outcomes such 
as pain scores were included in the study results, this study 
was not intended to be a validated outcomes study for pain 
or physical function. Rather, traditional outcome mea-
sures were only included to allow patients to give context 
to their subjective QoL responses, which were the primary 
data collected. The goal, simply, was to understand to what 
extent nerve injuries had a negative impact on quality of 
life, and whether nerve surgery broadly was helpful in 
improving QoL for these patients.
Findings of this study included characterization of the 
symptoms associated with nerve injuries that patients felt 
affected their QoL, the subjective severity of these symp-
toms, and their impact on QoL (Table  1, Figs.  1, 3, 6). 
Respondents in our study reported chronic nerve injuries 
affected the QoL domains of sleep, social functioning, and 
global QoL; findings that are in concordance with other 
studies that have used the SF-36 (short form 36) to dem-
onstrate an impact of medically-treated neuropathic pain 
on these domains.8 Our patients further reported impacts 
on professional activities, mood, and ambulation or use 
of extremity (as we queried patients with a broader set of 
Fig. 9. Patients’ feelings and experiences regarding referral process.
Fig. 10. Patients’ feelings regarding availability of information for treatment options.
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nerve injuries rather than only those causing neuropathic 
pain) (Table 1).
A majority of our patients reported chronic symp-
toms that were substantially disabling in their frequency, 
duration, and severity (Figs.  1, 3). Regarding the nega-
tive impact of nerve injury symptoms on QoL, 97.6% of 
patients reported at least a moderate impact, and 84.7% 
reported a significant impact on QoL (Fig. 6). The find-
ing of a negative impact on QoL is in agreement with 
prior population survey studies, wherein respondents 
with medically-treated neuropathic pain had lower SF-36 
HR-QOL (short form 36 health-related quality of life) 
scores than patients with non-neuropathic pain, even after 
adjusting for pain score.9,10 Taken together, our findings 
regarding duration and severity of symptoms, and level of 
impact on QoL indicate that this subset of nerve injury 
patients presenting for ambulatory nerve surgery had rela-
tively chronic, established conditions with a pronounced 
negative effect on QoL; perhaps because they are referred 
for surgery after other conditions have been tried and 
failed.
Although there are a multitude of published studies 
that report the outcome of nerve surgery in terms of VAS 
(visual analog scale) pain reduction and changes in a vari-
ety of physical functioning metrics, there are surprisingly 
few reports of the direct effect of nerve surgery on QoL.11 
Yang et al demonstrated an improvement in SF-36 scores 
in patients undergoing lower extremity nerve decompres-
sion surgery for painful diabetic neuropathy, in a case 
series of 19 patients.12 Domeshek et al reported a statis-
tically significant improvement in QoL rated on a VAS 
scale in a case series of 70 patients with upper and lower 
extremity neuromas.13 However, a meta-analysis examining 
surgical treatment of painful neuromas did not identify 
meaningful reporting on QoL from other publications.11 
Our results echo those of the few other studies reporting 
Fig. 11. Patients’ feelings on timeliness of referral and outcome.
Fig. 12. Patient satisfaction with nerve surgery.
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improvement in QoL following surgical treatment for 
nerve injuries, and our results are notable in compari-
son for examining both a larger cohort of patients and 
a broader range of chronic nerve injury conditions. The 
majority of respondents in our study reported that nerve 
surgery improved QoL to a significant (59.8%) or at least 
moderate (76.6%) degree, and at least 65% of patients 
reported specific improvements in each of the domains 
of sleep pattern, extremity function, personal/social life, 
professional productivity, and mood (Fig. 7). These data 
support the existing body of literature demonstrating that 
nerve injuries are associated with a negative impact on 
quality of life14–16 and that surgical treatment of nerve inju-
ries is an important consideration in patients’ care when a 
reasonable short period of conservative measures has not 
led to resolution of symptoms.3,11,13,17
The study findings also provided a description of the 
process of finding care for nerve injuries. Survey results 
confirmed that most patients had seen multiple specialists 
before referral for nerve surgery evaluation, and that many 
patients experienced subjective frustrations and delays 
during the referral process before ultimately undergoing 
evaluation by a nerve surgeon (Figs. 9–11). The majority 
of patients felt that they should have been referred earlier 
(Fig. 9), and most patients either were not told that nerve 
surgery was an option for them, or were told that nothing 
could be done for their problem (Figs.  9, 10). Notably, 
77% of patients felt that they were not managed in a timely 
manner and 83.1% felt that earlier referral would have 
improved their quality of life. We are not able to confirm 
with this study whether earlier surgical treatment would 
have improved outcomes of our patients in terms of pain 
reduction; however, Kato et al have demonstrated that 
delayed surgical treatment of brachial plexus injuries are 
associated with poorer pain outcomes in addition to the 
expected poorer functional outcomes.18 These findings 
appear to validate the assumption of many nerve surgeons 
that closer interdisciplinary care of nerve injury patients 
would reduce suffering for the patient and hasten recov-
ery in their personal, daily, professional, and social lives.
The overall importance of our findings should be inter-
preted in the context of interdisciplinary management 
and of the existing literature regarding management of 
chronic neuropathic pain. Outside of surgical literature 
and practice, the term “neuropathic pain” is broad, and 
includes pain resulting from phenomena varying from 
nonsurgical conditions such as postherpetic neuralgia, to 
conditions such as neuroma that result from nerve injury 
and have been repeatedly demonstrated to respond to sur-
gery.19 The predominance of published literature regard-
ing management of chronic neuropathic pain is medical 
or pharmacologic in scope and tends not to consider con-
ditions leading to neuropathic pain as surgically-treatable 
injuries of nerves. Thus, even though parallel surgical lit-
erature offers clear recommendations on timing for sur-
gical intervention for all types of nerve injuries, none of 
this literature is included in commonly referenced treat-
ment algorithms,20 guidelines,21–24 and society consensus 
statements25 that are used to guide medical treatment of 
chronic nerve injuries.
There are multiple examples of conditions whose 
pathophysiology and treatment are viewed differently by 
medical and surgical providers, and for which a shared 
terminology and concept of disease would likely improve 
multidisciplinary management to the benefit of patients. 
Our study population included, for instance, those with 
neuromas undergoing excision or excision and recon-
struction, those with painful diabetic neuropathy related 
to nerve compression, those with complex regional pain 
syndrome, and those with chronic headaches related to 
Fig. 13. Safety of nerve surgery.
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sensory nerve entrapment or injury. Multiple publica-
tions have shown that surgical treatment of neuromas 
improves pain11,26,27 and quality of life.13 Surgical litera-
ture is also replete with studies demonstrating improve-
ments in pain,28–31 sensibility,32–34 and quality of life12 after 
nerve decompression in painful diabetic neuropathy—a 
condition for which only pharmacologic treatment is tra-
ditionally considered in nonsurgical literature,20–25 despite 
extensive publications examining its negative impact on 
quality of life.35–38 Chronic migraine headaches, although 
traditionally considered a source of neuropathic pain 
only treatable with chronic medication, have also been 
repeatedly demonstrated to be treatable with surgical 
decompression of entrapped sensory nerves,38–41 or exci-
sion of neuroma in cases of nerve injury masquerading as 
headaches such as in postoperative headaches following 
acoustic neuroma excision that are associated with occipi-
tal nerve neuromas.42,43 The same circumstance has lately 
been recognized in phantom limb pain—a condition tra-
ditionally treated pharmacologically that has now been 
shown to be treatable with nerve transfer surgery.44,45 The 
greatest barrier to effective multidisciplinary treatment 
for these conditions seems to be one of terminology and 
ideation, and it may be this barrier that is partially respon-
sible for our findings of delayed presentation for surgical 
treatment. It stands to reason, therefore, that unified algo-
rithms with common terminology and incorporating both 
medical and surgical recommendations for treatment 
would improve patients’ outcomes and decrease the qual-
ity of life burden experienced by patients with chronic 
nerve injuries.
Limitations of the study include a relatively low response 
rate, which may have to do with attrition of respondents 
over a long study period. There were differences in survey 
response rates among surgery types; however, the percent-
age of respondents by surgery type generally approximated 
the percentage of the patients who had undergone that 
surgery type. The retrospective nature of the survey relies 
on patient recall, possibly affecting outcome interpreta-
tion. However, ultimately, it is the patient’s final impres-
sion of the experience after completion of treatment that 
we are concerned with. Arguably, the lack of a validated 
outcomes measure for quality of life is a weakness; how-
ever, we were specifically interested in patients’ responses 
to direct questions regarding QoL and the referral process, 
rather than validated but less specific surrogate measures. 
Despite these study limitations, this preliminary report 
does serve to call awareness to the issues of decreased qual-
ity of life and delays in referral for surgical care in patients 
suffering from chronic nerve injuries. Future prospective 
studies utilizing validated patient-reported outcome tools 
that measure QoL would add further perspective to these 
preliminary but significant findings.
CONCLUSIONS
Among patients with nerve injury referred for nerve 
surgery, most report decreased quality of life associated 
with their injury. Nerve injury patients also report that 
the referral process of finding appropriate surgical care 
may be frustrating or protracted, and that this further 
negatively impacts their ultimate outcome and quality of 
life. Greater recognition of the quality of life burden that 
nerve injury patients face while finding appropriate sur-
gical care for their condition should highlight the need 
for closer interdisciplinary management of these patients. 
Treatment algorithms incorporating both medical and 
surgical perspectives on the treatment of chronic neuro-
pathic pain would improve interdisciplinary management.
Ivica Ducic, MD, PhD
The George Washington University
Washington Nerve Institute
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